Tektite Genome is an AI-driven genomics Biotech company that develops and represents non-toxic products and services.
Tektite Genome has raised $2.4M in total funding. The most recent round was Series A. The last funding was announced in December 2025.
Tektite Genome's investors include Steven Crow.
Tektite Genome is headquartered in Long Beach, United States.
Tektite Genome is an AI-driven genomics Biotech company that develops and represents non-toxic products and services.
Tektite Genome is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Tektite Genome — Funding & Investors." VCBacked, December 10, 2025, https://www.vcbacked.co/company/tektite-genome. Accessed August 13, 2026.
VCBacked. (2025). Tektite Genome — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/tektite-genome
{{cite web |title=Tektite Genome — Funding & Investors |url=https://www.vcbacked.co/company/tektite-genome |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated